Literature DB >> 7866804

One-week low-dose triple therapy: new standards for Helicobacter pylori treatment.

A Goddard1, R Logan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7866804

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


× No keyword cloud information.
  8 in total

1.  H pylori infection.

Authors:  P S Phull; M R Jacyna
Journal:  Br J Gen Pract       Date:  1996-01       Impact factor: 5.386

2.  Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.

Authors:  M Tavakoli; A T Prach; M Malek; D Hopwood; B W Senior; F E Murray
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981

Review 3.  Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.

Authors:  A Fitton; L Wiseman
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

4.  How should we decide on the best regimen for eradicating Helicobacter pylori?

Authors:  V Savarino; S Vigneri
Journal:  BMJ       Date:  1995-09-02

5.  Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Authors:  P Moayyedi; D M Chalmers; A T Axon
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

6.  [Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].

Authors:  J Glaser; J Hein; R Daikeler; G Weithofer; M Vieth; M Schmidt; M Stolte
Journal:  Med Klin (Munich)       Date:  1998-02-15

7.  Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany.

Authors:  K Wolle; M Nilius; A Leodolter; W A Müller; P Malfertheiner; W König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

8.  The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study.

Authors:  P S Phull; S D Ryder; D Halliday; A B Price; A J Levi; M R Jacyna
Journal:  Postgrad Med J       Date:  1995-07       Impact factor: 2.401
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.